A carregar...

Effect of an oral gold compound, auranofin, on non-specific bronchial hyperresponsiveness in mild asthma.

BACKGROUND--A recent double blind clinical trial in Japan has shown that auranofin (6 mg/day) is a useful treatment for patients with moderate to severe asthma. To investigate the mechanism of action of auranofin the bronchial responsiveness to inhaled methacholine has been studied in well controlle...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Honma, M., Tamura, G., Shirato, K., Takishima, T.
Formato: Artigo
Idioma:Inglês
Publicado em: 1994
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC475050/
https://ncbi.nlm.nih.gov/pubmed/8066558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!